SCHEMBL6928402

SCHEMBL6928402

C=CCCCCCCCCCOc1cc[c]cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KCNA3 P22001 1/20 0.39
HTT P42858 1/20 0.39
LPAR3 Q9UBY5 2/20 0.38
LPAR2 Q9HBW0 1/20 0.38
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
SLC2A1 P11166 1/20 0.36
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL920629 1.00 ALDH1A1 (0.47) ALDH1A1L3MBTL1KCNA3HTTLPAR3
SCHEMBL921787 0.98 ALDH1A1 (0.49) ALDH1A1L3MBTL1KCNA3HTTLPAR3
SCHEMBL920772 0.92 ALDH1A1 (0.54) ALDH1A1L3MBTL1KCNA3HTTHDAC1
SCHEMBL920853 0.86 ALDH1A1 (0.43) ALDH1A1L3MBTL1KCNA3HTTHPGD
SCHEMBL15365357 0.86 ALDH1A1 (0.59) ALDH1A1L3MBTL1KCNA3HTTLPAR3
SCHEMBL8553182 0.84 L3MBTL1 (0.61) ALDH1A1L3MBTL1KCNA3HTTLPAR3
SCHEMBL5053411 0.81 KCNA3 (0.64) ALDH1A1L3MBTL1KCNA3HDAC3HDAC4
SCHEMBL14078010 0.81 ALDH1A1 (0.54) ALDH1A1L3MBTL1KCNA3HTTLPAR3
SCHEMBL18936005 0.81 KCNA3 (0.64) ALDH1A1L3MBTL1KCNA3HDAC3HDAC4
SCHEMBL9684375 0.81 KCNA3 (0.64) ALDH1A1L3MBTL1KCNA3HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514407-B2 For use as supports in separation or in preparation of enantiomers, by employing gaseous, liquid or supercritical chromatography, by electrophoresis, electrochromatography or by percolation processes through membranes INSTITUT FRANCAIS DU PETROLE (FR) 2003-02-04 US disclosed
US-20020058763-A1 Chloro-, hydroxy- and alkoxysilane derivatives of polysaccharides or oligosaccharides, polymerizable and cross-linkable, their synthesis and their use as sources of novel support materials INSTITUT FRANCAIS DU PETROLE (FR) 2002-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058763-A1 Chloro-, hydroxy- and alkoxysilane derivatives of polysaccharides or oligosaccharides, polymerizable and cross-linkable, their synthesis and their use as sources of novel support materials SI, SORD, HAO2 ALDH1A1 3013/4885L3MBTL1 3823/4885KCNA3 2043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.